Following the February 2011 acquisition of 02h, Piramal Pharma Solutions has re-branded its discovery chemistry and ADME services as Piramal Discovery Solutions. The re-branding reflects Piramal’s expansion into the contract discovery and development services. The company can now offer integrated drug discovery solutions from discovery chemistry to clinical trials. O2h’s discovery capabilities include integrated teams of FTE-based medicinal chemistry, synthetic chemistry and in-vitro ADMET. The...